Cenderitide

N/A

Report date: 2023/11/01 20:08:59

Base Information

Drug NameCenderitide
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionNatriuretic peptide receptor 1 agonistsAtrial natriuretic peptide receptor type B agonists
TargetsNatriuretic peptide receptor 1Atrial natriuretic peptide receptor type B
Therapy Area/IndicationsAcutely decompensated congestive heart failureMyocardial InfarctionHeart Failure +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRussian FederationGermany +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCapricor Therapeutics IncMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNile Therapeutics IncCapricor IncMayo Clinic
Active IndicationsN/A
Inactive IndicationsAcutely decompensated congestive heart failureMyocardial InfarctionHeart Failure +[4] 

Other Information

ATC CodeN/A
Related LinksN/A